Mihaela Onu1, Adina Aroceanu2, Victor Ferastraoaru3, Ovidiu Bajenaru4. 1. Department of Medical Imaging, Clinical Hospital "Prof. Dr. Th. Burghele", Bucharest, Romania. 2. Department of Neurology, Emergency University Hospital, Bucharest, Romania. 3. Department of Neurology, Montefiore Medical Center / Albert Einstein College of Medicine, New York, USA. 4. NoorDepartment of Neurology, Emergency University Hospital, Bucharest, Romania.
Abstract
BACKGROUND AND PURPOSE: Recent MR studies have shown that, in multiple sclerosis, selective regional, but not global gray matter atrophy occurs in multiple sclerosis. Our aim was to identify specific areas of gray matter volume changes and explore the relationship between atrophy and clinical motor outcomes. METHODS: Nine patients with relapsing remitting MS and 9 matched healthy controls were recruited. The Multiple Sclerosis Functional Composite was administered. For MR acquisitions, a GE- Genesis- Signa, 1.5T MR system, was used. A voxel-based morphometry (VBM), subcortical structures segmentation (FIRST) and volumetric (SIENAx) FSL tools were used in the study. RESULTS: Group comparison showed atrophy for several gray matter regions. The most important volume reductions were found for subcortical deep gray matter areas. Correlations with clinical scores were checked and specific gray matter areas showed significant volume reductions associated with motor scores (9-hole peg time and 25-feet walk time) and EDSS (Expanded Disability Status Scale). CONCLUSION: We performed a voxelwise analysis of gray matter changes in MS and found a more prominent atrophy for the subcortical structures than for cortical gray matter. Using an additional analysis (FIRST and SIENAx segmentation/volumetry) we were able to confirm the VBM results and to quantify the degree of atrophy in specific structures. Specific gray matter regions which volume reductions correlate with 25-feet walk, 9-hole peg times and EDSS suggest that 25-feet walk time is the best predictor of disease progression in terms of gray matter reduction.
BACKGROUND AND PURPOSE: Recent MR studies have shown that, in multiple sclerosis, selective regional, but not global gray matter atrophy occurs in multiple sclerosis. Our aim was to identify specific areas of gray matter volume changes and explore the relationship between atrophy and clinical motor outcomes. METHODS: Nine patients with relapsing remitting MS and 9 matched healthy controls were recruited. The Multiple Sclerosis Functional Composite was administered. For MR acquisitions, a GE- Genesis- Signa, 1.5T MR system, was used. A voxel-based morphometry (VBM), subcortical structures segmentation (FIRST) and volumetric (SIENAx) FSL tools were used in the study. RESULTS: Group comparison showed atrophy for several gray matter regions. The most important volume reductions were found for subcortical deep gray matter areas. Correlations with clinical scores were checked and specific gray matter areas showed significant volume reductions associated with motor scores (9-hole peg time and 25-feet walk time) and EDSS (Expanded Disability Status Scale). CONCLUSION: We performed a voxelwise analysis of gray matter changes in MS and found a more prominent atrophy for the subcortical structures than for cortical gray matter. Using an additional analysis (FIRST and SIENAx segmentation/volumetry) we were able to confirm the VBM results and to quantify the degree of atrophy in specific structures. Specific gray matter regions which volume reductions correlate with 25-feet walk, 9-hole peg times and EDSS suggest that 25-feet walk time is the best predictor of disease progression in terms of gray matter reduction.
Authors: Arnaud Charil; Alain Dagher; Jason P Lerch; Alex P Zijdenbos; Keith J Worsley; Alan C Evans Journal: Neuroimage Date: 2006-11-16 Impact factor: 6.556
Authors: Sonia Batista; Robert Zivadinov; Marietta Hoogs; Niels Bergsland; Mari Heininen-Brown; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict Journal: J Neurol Date: 2011-07-01 Impact factor: 4.849
Authors: Alberto Cifelli; Marzena Arridge; Peter Jezzard; Margaret M Esiri; Jacqueline Palace; Paul M Matthews Journal: Ann Neurol Date: 2002-11 Impact factor: 10.422
Authors: M K Houtchens; R H B Benedict; R Killiany; J Sharma; Z Jaisani; B Singh; B Weinstock-Guttman; C R G Guttmann; R Bakshi Journal: Neurology Date: 2007-09-18 Impact factor: 9.910
Authors: E M Mowry; A Beheshtian; E Waubant; D S Goodin; B A Cree; P Qualley; R Lincoln; M F George; R Gomez; S L Hauser; D T Okuda; D Pelletier Journal: Neurology Date: 2009-05-19 Impact factor: 9.910
Authors: Deepa Preeti Ramasamy; Ralph H B Benedict; Jennifer L Cox; David Fritz; Nadir Abdelrahman; Sara Hussein; Alireza Minagar; Michael G Dwyer; Robert Zivadinov Journal: J Neurol Sci Date: 2009-02-06 Impact factor: 3.181
Authors: Michael Sailer; Bruce Fischl; David Salat; Claus Tempelmann; Mircea Ariel Schönfeld; Evelina Busa; Nils Bodammer; Hans-Jochen Heinze; Anders Dale Journal: Brain Date: 2003-06-04 Impact factor: 13.501
Authors: Thorsten Rudroff; Alexandra C Fietsam; Justin R Deters; Craig D Workman; Laura L Boles Ponto Journal: Front Hum Neurosci Date: 2022-01-25 Impact factor: 3.169
Authors: Gilles Allali; Helena M Blumen; Hervé Devanne; Elvira Pirondini; Arnaud Delval; Dimitri Van De Ville Journal: Neurophysiol Clin Date: 2018-10-25 Impact factor: 3.734